These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30364225)

  • 1. Assessment and Management of Cognitive and Psychosocial Dysfunctions in Patients With Major Depressive Disorder: A Clinical Review.
    Fiorillo A; Carpiniello B; De Giorgi S; La Pia S; Maina G; Sampogna G; Spina E; Tortorella A; Vita A
    Front Psychiatry; 2018; 9():493. PubMed ID: 30364225
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
    Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
    J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder.
    Zuckerman H; Pan Z; Park C; Brietzke E; Musial N; Shariq AS; Iacobucci M; Yim SJ; Lui LMW; Rong C; McIntyre RS
    Front Psychiatry; 2018; 9():655. PubMed ID: 30564155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Deficits in the THINC-Integrated Tool (THINC-it) Are Associated With Psychosocial Dysfunction in Patients With Major Depressive Disorder.
    Knight MJ; Fourrier C; Lyrtzis E; Aboustate N; Sampson E; Hori H; Mills NT; Baune BT
    J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptoms of Major Depressive Disorder and Their Impact on Psychosocial Functioning in the Different Phases of the Disease: Do the Perspectives of Patients and Healthcare Providers Differ?
    Christensen MC; Wong CMJ; Baune BT
    Front Psychiatry; 2020; 11():280. PubMed ID: 32390877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder: psychosocial impairment and key considerations in functional improvement.
    Papakostas GI
    Am J Manag Care; 2009 Dec; 15(11 Suppl):S316-21. PubMed ID: 20088627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management.
    Culpepper L; Lam RW; McIntyre RS
    J Clin Psychiatry; 2017; 78(9):1383-1394. PubMed ID: 29345866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder.
    Knight MJ; Baune BT
    Front Psychiatry; 2018; 9():539. PubMed ID: 30420817
    [No Abstract]   [Full Text] [Related]  

  • 9. Social cognitive abilities predict psychosocial dysfunction in major depressive disorder.
    Knight MJ; Baune BT
    Depress Anxiety; 2019 Jan; 36(1):54-62. PubMed ID: 30211966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of desvenlafaxine on neurocognitive and work functioning in employed outpatients with major depressive disorder.
    Lam RW; Iverson GL; Evans VC; Yatham LN; Stewart K; Tam EM; Axler A; Woo C
    J Affect Disord; 2016 Oct; 203():55-61. PubMed ID: 27280963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosocial functioning during the treatment of major depressive disorder with fluoxetine.
    Papakostas GI; Petersen T; Denninger JW; Tossani E; Pava JA; Alpert JE; Nierenberg AA; Fava M
    J Clin Psychopharmacol; 2004 Oct; 24(5):507-11. PubMed ID: 15349006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relationship between cognitive impairment and psychosocial functioning in major depressive disorder: A systematic review.
    Cambridge OR; Knight MJ; Mills N; Baune BT
    Psychiatry Res; 2018 Nov; 269():157-171. PubMed ID: 30149273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cognitive impairment in psychosocial functioning in remitted depression.
    Knight MJ; Air T; Baune BT
    J Affect Disord; 2018 Aug; 235():129-134. PubMed ID: 29655074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder.
    Pan Z; Grovu RC; Cha DS; Carmona NE; Subramaniapillai M; Shekotikhina M; Rong C; Lee Y; McIntyre RS
    CNS Neurol Disord Drug Targets; 2017; 16(8):891-899. PubMed ID: 28933261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating to target in major depressive disorder: response to remission to functional recovery.
    McIntyre RS; Lee Y; Mansur RB
    CNS Spectr; 2015 Dec; 20 Suppl 1():20-30; quiz 31. PubMed ID: 26683526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In pursuit of full recovery in major depressive disorder.
    M VG; M SB; G NV; J T; V BM; Mj P; N C
    Eur Arch Psychiatry Clin Neurosci; 2023 Aug; 273(5):1095-1104. PubMed ID: 36085532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between neurocognitive and psychosocial functioning in major depressive disorder: a systematic review.
    Evans VC; Iverson GL; Yatham LN; Lam RW
    J Clin Psychiatry; 2014 Dec; 75(12):1359-70. PubMed ID: 25551235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction in major depressive disorder: a state-of-the-art clinical review.
    Bortolato B; Carvalho AF; McIntyre RS
    CNS Neurol Disord Drug Targets; 2014; 13(10):1804-18. PubMed ID: 25470396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction in major depression: From assessment to novel therapies.
    Atique-Ur-Rehman H; Neill JC
    Pharmacol Ther; 2019 Oct; 202():53-71. PubMed ID: 31173838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing and measuring cognitive function in major depressive disorder.
    Ragguett RM; Cha DS; Kakar R; Rosenblat JD; Lee Y; McIntyre RS
    Evid Based Ment Health; 2016 Nov; 19(4):106-109. PubMed ID: 27935809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.